Advertisement
Advertisement
U.S. Markets open in 8 hrs 56 mins
Advertisement
Advertisement
Advertisement
Advertisement

Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKSE - HKSE Delayed Price. Currency in HKD
7.2300.000 (0.00%)
As of 10:26AM HKT. Market open.
Advertisement

Charmacy Pharmaceutical Co., Ltd.

No. 235, Song Shan North Road
Longhu District
Shantou 515041
China
86 754 8820 6420
https://www.chmyy.com

Sector(s)Healthcare
IndustryMedical Distribution
Full Time Employees820

Key Executives

NameTitlePayExercisedYear Born
Mr. Chuanglong YaoChairman & CEO94.5kN/A1970
Ms. Yuyan ZhengChief Marketing Officer, VP & Exec. Director71.38kN/A1975
Ms. Hanzi ZhangPerson-In-Charge of Fin. & Exec. DirectorN/AN/A1979
Mr. Zhijie LinChief Logistics Officer & SupervisorN/AN/A1984
Ms. Wai Ling WongJoint Company Sec.N/AN/AN/A
Ms. Jiexi YaoJoint Company Sec.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.

Corporate Governance

Charmacy Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement